跳至主要内容
临床试验/NCT05527626
NCT05527626招募中不适用

Chronic Kidney Disease - REAL Life Study in Alsace

University Hospital, Strasbourg, France1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2022年2月17日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
3,000
试验地点
1
主要终点
Retroanalysis of the risk factors in patients with severe chronic kidney disease

研究概览

简要总结

Chronic kidney disease (CKD) is a public health problem and affects about 10% of the world's adult population with a constantly increasing incidence. The approach to CKD in France is centered on access to replacement therapy (dialysis, renal transplantation), the cost of which amounts to 4 billion euros (data from the REIN registry).

Real-life data are essential to specify the characteristics of patients with chronic kidney disease and the factors associated with the evolution of CKD and the occurrence of complications in order to improve the management of CKD before the suppletion stage.

Since October 2019, CKD at the severe stage (stage 4) and at the non-dialysis end stage (stage 5) is subject to an annual flat fee (Article L. 162-22-6-2 of the Social Security Code). The reimbursement of these lump sums by the health insurance is subject to the collection and transmission of certain medical data by the establishments.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Retroanalysis of the risk factors in patients with severe chronic kidney disease

时间窗: Files analysed retrospectively from October 01, 2019 to February 31, 2027 will be examined

Analysis of risk factors in patients with severe chronic kidney disease by retrospectively analyzing health data contained in patient medical records

次要结局

未报告次要终点

研究者

发起方
University Hospital, Strasbourg, France
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验